- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/56 - BenzopyrazolesHydrogenated benzopyrazoles
Patent holdings for IPC class C07D 231/56
Total number of patents in this class: 1729
10-year publication summary
|
135
|
123
|
137
|
141
|
117
|
119
|
99
|
113
|
102
|
59
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3741 |
35 |
| Nerviano Medical Sciences S.r.l. | 256 |
28 |
| Takeda Pharmaceutical Company Limited | 2709 |
27 |
| F. Hoffmann-La Roche AG | 7921 |
26 |
| Bristol-myers Squibb Company | 4893 |
25 |
| Glaxo Group Limited | 4068 |
23 |
| Janssen Pharmaceutica N.V. | 3383 |
23 |
| Array BioPharma Inc. | 502 |
22 |
| LG Chem, Ltd. | 17638 |
21 |
| Merck Sharp & Dohme Corp. | 2190 |
21 |
| Abbvie Inc. | 1801 |
20 |
| Bayer Pharma AG | 1047 |
17 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 827 |
17 |
| Merck Patent GmbH | 5823 |
15 |
| The Regents of the University of California | 19929 |
14 |
| Boehringer Ingelheim International GmbH | 4648 |
14 |
| Abbott Laboratories | 2398 |
14 |
| AstraZeneca AB | 2908 |
13 |
| Genentech, Inc. | 3980 |
12 |
| Pfizer Inc. | 3381 |
12 |
| Other owners | 1330 |